Last reviewed · How we verify

NCT06223672: EFFECT

Essential Fats For Enhancing Cognitive Thinking (EFFECT) Study

Recruiting now NA Last updated 8 August 2025
What this trial tests

NA trial testing Walnuts in Cognitive Decline in 88 participants. Currently enrolling.

Timeline
7 February 2024
Primary endpoint
31 December 2025
31 May 2026

Quick facts

Lead sponsorOhio State University
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationrandomized
Designcrossover
Maskingsingle
Primary purposetreatment
Enrollment88
Start date7 February 2024
Primary completion31 December 2025
Estimated completion31 May 2026
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Ohio State University

Who can join

Adults 40 to 75, any sex, with Cognitive Decline or Cognitive Impairment. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The proposed research is a randomized crossover trial designed to assess changes in postprandial cognitive function and the gut-brain axis in adults with subjective cognitive complaints who consume 1 study snack per day for 1 week.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Effects of Walnuts on Postprandial Cognitive Function in Adults With Subjective Cognitive Impairment: Protocol for a Randomized Crossover Trial.
    Zarich S, Cole RM, Fairchild K, Spakowicz D, et al · · 2025 · PMID 41418290 · DOI 10.2196/82032

Verify or expand the search:

Other trials of Walnuts

Trials testing the same drug.

Other recruiting trials for Cognitive Decline

Currently open trials in the same condition.

Other Ohio State University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06223672.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing